Response of circulating metabolites to an oral glucose challenge and risk of cardiovascular disease and mortality in the community

被引：0
|
作者：
Daniel Gonzalez Izundegui
Patricia E. Miller
Ravi V. Shah
Clary B. Clish
Maura E. Walker
Gary F. Mitchell
Robert E. Gerszten
Martin G. Larson
Ramachandran S. Vasan
Matthew Nayor
机构：
[1] Boston University School of Medicine,Department of Medicine
[2] Boston University School of Public Health,Department of Biostatistics
[3] Vanderbilt University Medical Center,Vanderbilt Translational and Clinical Research Center, Cardiology Division
[4] Broad Institute of MIT and Harvard,Section of Preventive Medicine and Epidemiology, Department of Medicine
[5] Boston University School of Medicine,Department of Health Sciences, Program in Nutrition, Sargent College of Health and Rehabilitation Sciences
[6] Boston University,Boston University’s and National Heart
[7] Lung,Division of Cardiovascular Medicine
[8] and Blood Institute’s Framingham Heart Study,Section of Cardiovascular Medicine, Department of Medicine
[9] Cardiovascular Engineering,Department of Epidemiology, Boston University Schools of Medicine and Public Health, Center for Computing and Data Sciences
[10] Inc,undefined
[11] Beth Israel Deaconess Medical Center,undefined
[12] Boston University School of Medicine,undefined
[13] Boston University,undefined
来源：
Cardiovascular Diabetology | / 21卷
关键词：
Metabolism; Metabolomics; Prevention; Cardiovascular disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study
    von Kaenel, Roland
    Hamer, Mark
    Wentzel, Annemarie
    Malan, Leone
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [42] Circulating Markers of Liver Function and Cardiovascular Disease Risk
    Targher, Giovanni
    Byrne, Christopher D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2015, 35 (11) : 2290 - 2296
  • [43] Circulating neurotrophins and hemostatic risk factors of atherothrombotic cardiovascular disease at baseline and during sympathetic challenge: the SABPA study
    Roland von Känel
    Mark Hamer
    Annemarie Wentzel
    Leoné Malan
    Scientific Reports, 11
  • [44] Fasting blood glucose and risk of cardiovascular disease - Response to Balkau et al.
    Bjornholt, JV
    Sandvik, L
    Jervell, J
    Erikssen, J
    DIABETES CARE, 1999, 22 (08) : 1386 - 1387
  • [45] Fasting and 2-hour post-challenge glucose measures and risk of cardiovascular disease in the elderly: The Cardiovascular Health Study
    Smith, NL
    Barzilay, JI
    Shaffer, D
    Savage, PJ
    Heckbert, SR
    Kuller, LH
    Kronmal, RA
    Resnick, HE
    Psaty, BM
    CIRCULATION, 2000, 102 (18) : 871 - 871
  • [46] Impaired fasting glucose and risk of cardiovascular mortality in Korean adults
    Kim, Nam Hoon
    Kim, Kyoung Jin
    Kim, Kyeong Jin
    An, Jee Hyun
    Yoo, Hye Jin
    Kim, Hee Young
    Seo, Ji A.
    Kim, Nan Hee
    Choi, Kyung Mook
    Baik, Sei Hyun
    Choi, Dong Seop
    Kim, Sin Gon
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S205 - S206
  • [47] Circulating surfactant protein-D and the risk of cardiovascular morbidity and mortality
    Hill, John
    Heslop, Claire
    Man, S. F. Paul
    Frohlich, Jiri
    Connett, John E.
    Anthonisen, Nick R.
    Wise, Robert A.
    Tashkin, Donald P.
    Sin, Don D.
    EUROPEAN HEART JOURNAL, 2011, 32 (15) : 1918 - 1925
  • [48] Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge - Response
    Alderman, MH
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2002, 31 (02) : 331 - 332
  • [49] Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate
    Adam Hulman
    Dorte Vistisen
    Charlotte Glümer
    Michael Bergman
    Daniel R. Witte
    Kristine Færch
    Diabetologia, 2018, 61 : 101 - 107
  • [50] Glucose patterns during an oral glucose tolerance test and associations with future diabetes, cardiovascular disease and all-cause mortality rate
    Hulman, Adam
    Vistisen, Dorte
    Glumer, Charlotte
    Bergman, Michael
    Witte, Daniel R.
    Faerch, Kristine
    DIABETOLOGIA, 2018, 61 (01) : 101 - 107
12345